Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ENTA holding history

Enanta Pharmaceuticals Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings

Shares (Q2 2026)
557,600
Value
$8.13M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ENTA by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026557,600$8.13M<0.1%−107,658−16.2%ReducedHolders
Q1 2026665,258$8.40M<0.1%+23,058+3.6%AddedHolders
Q4 2025642,200$10.1M<0.1%+162,600+33.9%AddedHolders
Q3 2025479,600$5.74M<0.1%+10,100+2.2%AddedHolders
Q2 2025469,500$3.55M<0.1%+5,900+1.3%AddedHolders
Q1 2025463,600$2.56M<0.1%−34,400−6.9%ReducedHolders
Q4 2024498,000$2.86M<0.1%−26,900−5.1%ReducedHolders
Q3 2024524,900$5.44M<0.1%+14,000+2.7%AddedHolders
Q2 2024510,900$6.63M<0.1%−15,200−2.9%ReducedHolders
Q1 2024526,100$9.19M<0.1%−32,400−5.8%ReducedHolders
Q4 2023558,500$5.25M<0.1%+100,400+21.9%AddedHolders
Q3 2023458,100$5.12M<0.1%−18,200−3.8%ReducedHolders
Q2 2023476,300$10.2M<0.1%+48,836+11.4%AddedHolders
Q1 2023427,464$17.3M<0.1%−45,736−9.7%ReducedHolders
Q4 2022473,200$22.0M<0.1%+5,200+1.1%AddedHolders
Q3 2022468,000$24.3M<0.1%−74,800−13.8%ReducedHolders
Q2 2022542,800$25.7M<0.1%−64,300−10.6%ReducedHolders
Q1 2022607,100$43.2M0.1%−107,300−15.0%ReducedHolders
Q4 2021714,400$53.4M0.1%−42,185−5.6%ReducedHolders
Q3 2021756,585$43.0M0.1%−41,143−5.2%ReducedHolders
Q2 2021797,728$35.1M<0.1%−102,472−11.4%ReducedHolders
Q1 2021900,200$44.4M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.